Nicotinamide Sterop

Nicotinamide, the active ingredient in Nicotinamide Sterop, is a Vitamin B3 (niacinamide) presented as a sterile solution for Intramuscular, Intravenous use. It is employed to prevent and treat niacin (vitamin B3) deficiency and to support cellular NAD+ levels in metabolic disorders. GNH USA supplies Nicotinamide Sterop as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nicotinamide Sterop is used in the management of conditions related to vitamin B3 deficiency and NAD+ metabolism. - Niacin deficiency: restores normal levels of vitamin B3 and prevents associated pellagra symptoms. - Metabolic disorders: supports NAD+ synthesis, aiding cellular energy metabolism in conditions such as mitochondrial dysfunction. - Dermatologic support: may improve skin barrier function in certain skin conditions where niacinamide is indicated.

Nicotinamide Sterop may be associated with a range of adverse reactions following intramuscular or intravenous administration.

Common Side Effects: - Injection site pain or erythema - Mild headache - Transient nausea or gastrointestinal discomfort - Low‑grade fever - Dizziness

Serious or Rare Side Effects: - Anaphylactic reaction - Severe hypotension - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Significant liver enzyme elevation - Hyperuricemia

When using Nicotinamide Sterop, consider the following safety measures. - Assess renal function: adjust use in patients with severe renal impairment. - Monitor liver enzymes: watch for hepatic toxicity during prolonged therapy. - Evaluate hypersensitivity: discontinue if signs of allergic reaction appear. - Use caution in pregnancy: safety data are limited; prescribe only if benefit outweighs risk. - Avoid in patients with gout: nicotinamide may increase uric acid levels. - Store at ambient temperature: keep in original container, protect from moisture and light.

Nicotinamide may interact with other medicines, requiring attention to potential effects.

Major Interactions (Avoid): - Concurrent high‑dose niacin: may exacerbate flushing and hepatotoxicity. - Hepatotoxic drugs (e.g., isoniazid, methotrexate): increase risk of liver injury. - Anticoagulants (warfarin): may potentiate bleeding risk.

Moderate Interactions (Monitor Closely): - Alcohol: can heighten liver enzyme elevations. - Antihypertensives: nicotinamide may modestly lower blood pressure. - Antidiabetic agents: may affect glucose control. - Seizure medications: possible alteration of plasma levels. - Oral contraceptives: may increase plasma nicotinamide concentrations.